Cargando…

Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer

PURPOSE: This study aims to establish whether metabolic parameters obtainable from FCH PET/CT can predict long-term response to radical radiotherapy (rRT) in patients with localized prostate cancer (PCa). METHODS: Drawing on a single-center database, we retrospectively reviewed the pre-treatment FCH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sepulcri, Matteo, Fusella, Marco, Cuppari, Lea, Zorz, Alessandra, Paiusco, Marta, Evangelista, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361027/ https://www.ncbi.nlm.nih.gov/pubmed/34409175 http://dx.doi.org/10.1016/j.ctro.2021.07.002

Ejemplares similares

Role of radiomic analysis of [(18)F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging
por: Marturano, Francesca, et al.
Publicado: (2023)

[(18)F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer
por: Pasqualetti, Francesco, et al.
Publicado: (2019)

Diagnostic accuracy of F-18-Fluorocholine PET/CT and multiparametric MRI for prostate cancer
por: Kim, Jung Kwon, et al.
Publicado: (2022)

Detection of an undescended parathyroid adenoma with (18)F-fluorocholine PET/CT
por: Booij, J., et al.
Publicado: (2022)

Preoperative Imaging with [(18)F]-Fluorocholine PET/CT in Primary Hyperparathyroidism
por: Dekorsy, Franziska J., et al.
Publicado: (2022)

Incidental Findings on (18) F-Fluorocholine PET/CT for Parathyroid Imaging
por: Broos, Wouter A.M., et al.
Publicado: (2022)

Intra-vagal parathyroid adenoma on digital PET/CT with (18)F-fluorocholine
por: Mainta, Ismini C., et al.
Publicado: (2021)

Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging
por: Kwee, Sandi A., et al.
Publicado: (2012)

Detection of recurrence sites using (18)F-fluorocholine PET/CT in prostate cancer patients with PSA failure
por: Kim, Dong-Yun, et al.
Publicado: (2023)

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT
por: Kwee, Sandi A., et al.
Publicado: (2015)

Optimal scan time for evaluation of parathyroid adenoma with [(18)F]-fluorocholine PET/CT
por: Rep, Sebastijan, et al.
Publicado: (2015)

Detection of Synchronous Parathyroid Adenoma and Breast Cancer with (18)F-Fluorocholine PET-CT
por: Vorselaars, Wessel MCM, et al.
Publicado: (2015)

COVID-19 Pneumonia was Incidentally Detected on (18)F-Fluorocholine PET/CT in a Work-up for Prostate Cancer
por: Sahel, Omar Ait, et al.
Publicado: (2022)

Differentiation of hepatocellular adenoma and focal nodular hyperplasia using (18)F-fluorocholine PET/CT
por: van den Esschert, Jacomina W., et al.
Publicado: (2010)

(18)F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism
por: Latge, Adrien, et al.
Publicado: (2021)

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
por: De Giorgi, Ugo, et al.
Publicado: (2014)

Diagnostic Performance of [(18)F]Fluorocholine and [(68)Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
por: Paymani, Zeinab, et al.
Publicado: (2020)

(18)F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism
por: Pretet, Valentin, et al.
Publicado: (2020)

High turnover renal osteodystrophy due to secondary hyperparathyroidism diagnosed by (18)F-Fluorocholine combined with (18)F-NaF PET/CT
por: Xiong, Lin, et al.
Publicado: (2021)

Measurement of Circulating Cell‐Free DNA in Relation to 18F‐Fluorocholine PET/CT Imaging in Chemotherapy‐Treated Advanced Prostate Cancer
por: Kwee, Sandi, et al.
Publicado: (2012)

Interim and end-treatment (18)F-Fluorocholine PET/CT and bone scan in prostate cancer patients treated with Radium 223 dichloride
por: García Vicente, Ana María, et al.
Publicado: (2021)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

Comparison of (18)F-sodium fluoride PET/CT, (18)F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France
por: Gauthé, Mathieu, et al.
Publicado: (2020)

Visualization of Macroprolactinoma by (18)F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2018)

Hyperfunctioning parathyroid gland and skeletal involvement on [(18)F]fluorocholine PET/CT: one look with two views
por: Nappi, Carmela, et al.
Publicado: (2022)

Dural Metastases of Advanced Prostate Cancer Detected by (18)F-Fluorocholine
por: Morassi, Mauro, et al.
Publicado: (2020)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2016)

Additional Value of PET and CT Image-Based Features in the Detection of Occult Lymph Node Metastases in Lung Cancer: A Systematic Review of the Literature
por: Guglielmo, Priscilla, et al.
Publicado: (2023)

Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [(18)F]DCFPyL-PET: comparison to [(18)F]fluorocholine-PET
por: Yang, Dae-Myoung, et al.
Publicado: (2021)

PET/CT and the Response to Immunotherapy in Lung Cancer
por: Evangelista, Laura, et al.
Publicado: (2020)

Incremental role of (18)F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism
por: Behera, Abhishek, et al.
Publicado: (2016)

The Significance of 18F-Fluorocholine-PET/CT as Localizing Imaging Technique in Patients with Primary Hyperparathyroidism and Negative Conventional Imaging
por: Fischli, Stefan, et al.
Publicado: (2018)

Misleading localization by (18)F-fluorocholine PET/CT in familial hypocalciuric hypercalcemia type-3: a case report
por: Mukhtar, Noha N, et al.
Publicado: (2021)

Does (18)F-Fluorocholine PET/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism?
por: Imperiale, Alessio, et al.
Publicado: (2023)

Detection of lymph node metastases in patients with prostate cancer: Comparing conventional and digital [(18)F]‐fluorocholine PET‐CT using histopathology as a reference
por: Bjöersdorff, Mimmi, et al.
Publicado: (2022)

Prognostic Value of (18)F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
por: Quaquarini, E., et al.
Publicado: (2019)

Phase III Study of (18)F-PSMA-1007 Versus (18)F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
por: Olivier, Pierre, et al.
Publicado: (2023)

(18)F-Fluorocholine PET–CT enables minimal invasive parathyroidectomy in patients with negative sestamibi SPECT–CT and ultrasound: A case report
por: Kluijfhout, Wouter P., et al.
Publicado: (2015)

Troubleshooting for F-18 Fluorocholine Synthesis: An Institutional Experience
por: Vatsa, Rakhee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i6ifsv2kji090hjmv6ufkbt6h6